Mr. President, I just wish to indicate my support for the amendment offered by the Senator from Louisiana. Although it is drafted a little differently than I would have done it, it does address a real problem; that is, when the President--this President or any President--creates a new position within the White House that is duplicative of a Cabinet member's responsibilities, the result is we lose our ability to exercise accountability for the policies that individual comes up with. Let me give you a specific example. EPA is a Senate-Presidential appointee, Senate-confirmed position, the Administrator of the EPA. Yet President Obama created a position within the White House where there is essentially an environmental czar, and this individual--Carol Browner, who has since left, actually negotiated a deal with the automobile industry having to do with emissions. Well, the problem with that is, it is circumventing Congress's ability to hold accountable the person who is involved in making and coordinating that policy. What the Senator from Louisiana is trying to get at is the creation of these unaccountable czars within the White House who are doing the job that is supposed to be done by a Cabinet official, by a Presidentially appointed, Senate-confirmed official. So I support the amendment. I yield the floor. The PRESIDING OFFICER. The senior Senator from New York is recognized.
On the recordJune 23, 2011
Source
govinfo.govShare & report
More from Susan Collins
Jan 22, 2025
They commit larger and more heinous crimes, and that is exactly what happened here in the Laken Riley murder. Mr. Speaker, I encourage all of my colleagues to get this passed today. Let's get this done. I will leave you with one other…
Dec 3, 2024
Mr. President, Senator Joe Manchin often recalls these words of wisdom from his grandmother: People don't care how much you know until they know how much you care. Knowledge and caring define Joe's public service, both here in the Senate…
Jun 10, 2025
It is leading to scientists leaving the United States for opportunities in other countries. It’s causing clinical trials to be halted and promising medical research to be abandoned.





